Fig. 1From: Perfect match: mTOR inhibitors and tuberous sclerosis complexClinical features of TSC are diverse and involve multiple systems. The most frequently affected systems, their associated lesions, and examination methods are shown. Percentages represent the approximate incidence in patients with tuberous sclerosis complex (TSC). AML angiomyolipomas; cRHM cardiac rhabdomyoma; LAM lymphangioleiomyomatosis; MMPH multifocal micronodular pneumocyte hyperplasia; PKD polycystic kidney disease; RAH retinal astrocytic hamartoma; RCC renal cell carcinoma; SEGA subependymal giant cell astrocytoma; SEN subependymal nodule; TAND tuberous sclerosis complex-associated neuropsychiatric disorderBack to article page